Mauna Kea Technologies announced a leadership transition intended to enable the Company's next phase of commercial success. At the conclusion of a global executive search, the company Board of Directors has unanimously appointed Robert L. Gershon as Chief Executive Officer, effective October 22, 2018. A seasoned executive with over 30 years of experience directing commercial strategies and marketing execution for leading medical technology companies, Rob was most recently Chief Executive Officer of Bovie Medical, where he oversaw the successful repositioning of the company's product portfolio and commercial operations.

Prior roles included leadership positions with Henry Schein and Covidien (now Medtronic). Rob has been serving as an advisor to Mauna Kea for several months. As part of the leadership transition, Sacha Loiseau will become Chairman of the Board of Directors, where he can continue to contribute his expertise, knowledge and experience in an expanded role.

Working closely with Rob over the past six months, he has demonstrated his deep industry knowledge, operating discipline and commercial acumen. Additionally, the Board has appointed Christophe Lamboeuf as Deputy Managing Director, reflecting his significant and valuable contributions to the company as Chief Financial Officer. Finally, Jean-Luc Boulnois, Ph.D. has resigned from the company Board of Directors.

All of these changes were approved by the Board on October 10, 2018 and will become effective on October 22, 2018 following a planned transition period.